Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,034 public trials 567 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Active, Not Recruiting

Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

NCT04270409

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • UCLA Site Number : 8400010 Los Angeles, California, United States
  • Colorado Blood Cancer Institute Site Number : 8400007 Denver, Colorado, United States
  • Cancer Specialist of North Florida Site Number : 8400011 Jacksonville, Florida, United States
  • University of Miami Site Number : 8400012 Miami, Florida, United States
View all 105 locations
View Trial Details
Active, Not Recruiting

Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)

NCT04184050

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
View Trial Details
Active, Not Recruiting

Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia

NCT03620903

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Studiengesellschaft Onkologie Bielefeld GbR Bielefeld, Germany
  • DIAKO Ev. Diakonie-Krankenhaus gGmbH, Med. Klinik II Bremen, Germany
  • Universitätsklinikum Halle, Klinik für Innere Medizin IV Halle, Germany
  • Universtätsmedizin Mannheim, III. Medizinische Klinik Studienzentrale im MCC Mannheim, Germany
View Trial Details
Active, Not Recruiting

A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma

NCT05028348

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CHRU Hôtel Dieu Nantes, France
  • CHU Hôpital Saint Antoine Paris, France
  • La Pitié Paris, France
  • Klinikum Chemnitz Chemnitz, Germany
View all 20 locations
View Trial Details
Active, Not Recruiting

Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

NCT01838512

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution Birmingham, Alabama, United States
  • Local Institute Goodyear, Arizona, United States
  • Local Institution - 0023 Anaheim, California, United States
  • Local Institution Anaheim, California, United States
View all 130 locations
View Trial Details
Active, Not Recruiting

A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma

NCT04174196

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Commack Commack, New York, United States
View Trial Details

Related conditions